With $30 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI), Merck & Co. | The project, which involves Merck, SK Biosciences, Hilleman Laboratories and CDMO IDT ...

Merck & Co., Inc. (NYSE:MRK) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported that Merck & Co., ...

“Through this CEPI-supported partnership, SK bioscience will continue to play a critical role in improving Zaire ebolavirus ...

Jan 21 (Reuters) - Merck & Co unit MSD and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have ...

A major breakthrough in the fight against Zaire ebolavirus was announced at the World Economic Forum in Davos. CEPI (the Coalition for Epidemic Preparedness Innovations) is partnering with the ...

MSD and the Coalition for Epidemic Preparedness Innovations have launched a $30 million initiative to improve the ...

In a statement sent to PREMIUM TIMES on Friday, CEPI said the project is designed to address long-standing challenges around the cost, supply and deployment of the vaccine, particularly in ...

A new research partnership will test cutting-edge vaccines designed to protect against some of the world's most dangerous ...

Merck's affordable Ebola vaccine initiatives, Abbott's profit challenges, U.S. vaccination policy changes under Health ...

The vaccine, called rVSV-ZEBOV, was studied in a trial involving 11,841 people in Guinea during 2015. Among the 5,837 people who received the vaccine, no Ebola cases were recorded 10 days or more ...

April 1 -- MONDAY, March 31 (HealthDay News) -- Researchers have successfully tested several Ebola vaccines in monkeys and are now working to create the first human vaccine for one of the world's ...

Jan 21 (Reuters) - Merck and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have partnered on a ...